Skip to main content

Table 3 Univariate and multivariate analysis of possible factors associated with low eGFR at week 24 after switching NRTI

From: Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

Parameters

Univariate analysis

Multivariate analysis

 

Beta

95%CI of Beta

P value

Beta

95%CI of Beta

P value

eGFR at week 0

0.572

0.342 to 0.743

<0.001

0.529

0.296 to 0.707

<0.001

Receiving efavirenz

0.331

3.734 to 24.596

0.009

0.245

1.438 to 19.521

0.024

Age

-0.228

-1.325 to 0.063

0.074

-0.016

-0.649 to 0.562

0.886